Attitudes, beliefs, and practices among Swiss chiropractors regarding medication prescribing for musculoskeletal conditions: a national Q-methodology study.


Journal

Chiropractic & manual therapies
ISSN: 2045-709X
Titre abrégé: Chiropr Man Therap
Pays: England
ID NLM: 101551481

Informations de publication

Date de publication:
20 10 2020
Historique:
received: 14 05 2020
accepted: 04 10 2020
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 27 2 2021
Statut: epublish

Résumé

Swiss chiropractors have been licensed since 1995 to prescribe from a limited formulary of medications for treating musculoskeletal (MSK) conditions. In January 2018, this formulary was expanded to include additional muscle relaxant, analgesic, and anti-inflammatory medications. Internationally, controversy remains over whether or not medication prescribing should be pursued within the chiropractic profession. The purpose of this study was to assess Swiss chiropractors' attitudes, beliefs, and practices regarding their existing medication prescription privileges. This information will provide new insights on the topic and help inform research and policy discussions about expanding chiropractic prescription rights in other jurisdictions. A 13-item questionnaire and Q-methodology approach were used to conduct the assessment. Recruitment was conducted by e-mail between December 2019 and February 2020, and all members of the Swiss Chiropractic Association were eligible to participate. Data were analyzed using by-person factor analysis and descriptive statistics. In total, 187 Swiss chiropractors participated in this study (65.4% response rate). Respondents reported prescribing analgesics, anti-inflammatories, and muscle relaxants to a median of 5, 5, and 0% of patients, respectively. Forty-two percent of respondents expressed interest in further expanding the range of current medications available to Swiss chiropractors for treating MSK conditions. Only 15% expressed interest in expanding this range to include medications for treating non-MSK conditions. In the Q-methodology analysis, four salient viewpoints/groups regarding medication prescribing emerged: prescribers, non-prescribers, collaborators, and integrators. All except non-prescribers thought medication prescription privileges were advantageous for the chiropractic profession in Switzerland. There was also strong consensus among all four groups that medication prescribing should not replace manual therapy in chiropractic practice. This was the first national survey on attitudes toward prescribing medications among Swiss chiropractors since the year 2000, and the first using Q-methodology. With this approach, four unique groups of chiropractic prescribers were identified. Even with diversity among clinicians, the findings of this study showed general support for, along with conservative use of, prescribing privileges within the Swiss chiropractic profession. Studies in jurisdictions outside of Switzerland are needed to assess whether chiropractors are interested in expanding their scopes of practice to include similar prescribing privileges.

Sections du résumé

BACKGROUND
Swiss chiropractors have been licensed since 1995 to prescribe from a limited formulary of medications for treating musculoskeletal (MSK) conditions. In January 2018, this formulary was expanded to include additional muscle relaxant, analgesic, and anti-inflammatory medications. Internationally, controversy remains over whether or not medication prescribing should be pursued within the chiropractic profession.
OBJECTIVE
The purpose of this study was to assess Swiss chiropractors' attitudes, beliefs, and practices regarding their existing medication prescription privileges. This information will provide new insights on the topic and help inform research and policy discussions about expanding chiropractic prescription rights in other jurisdictions.
METHODS
A 13-item questionnaire and Q-methodology approach were used to conduct the assessment. Recruitment was conducted by e-mail between December 2019 and February 2020, and all members of the Swiss Chiropractic Association were eligible to participate. Data were analyzed using by-person factor analysis and descriptive statistics.
RESULTS
In total, 187 Swiss chiropractors participated in this study (65.4% response rate). Respondents reported prescribing analgesics, anti-inflammatories, and muscle relaxants to a median of 5, 5, and 0% of patients, respectively. Forty-two percent of respondents expressed interest in further expanding the range of current medications available to Swiss chiropractors for treating MSK conditions. Only 15% expressed interest in expanding this range to include medications for treating non-MSK conditions. In the Q-methodology analysis, four salient viewpoints/groups regarding medication prescribing emerged: prescribers, non-prescribers, collaborators, and integrators. All except non-prescribers thought medication prescription privileges were advantageous for the chiropractic profession in Switzerland. There was also strong consensus among all four groups that medication prescribing should not replace manual therapy in chiropractic practice.
CONCLUSION
This was the first national survey on attitudes toward prescribing medications among Swiss chiropractors since the year 2000, and the first using Q-methodology. With this approach, four unique groups of chiropractic prescribers were identified. Even with diversity among clinicians, the findings of this study showed general support for, along with conservative use of, prescribing privileges within the Swiss chiropractic profession. Studies in jurisdictions outside of Switzerland are needed to assess whether chiropractors are interested in expanding their scopes of practice to include similar prescribing privileges.

Identifiants

pubmed: 33076943
doi: 10.1186/s12998-020-00341-6
pii: 10.1186/s12998-020-00341-6
pmc: PMC7574492
doi:

Substances chimiques

Analgesics 0
Anti-Inflammatory Agents 0
Neuromuscular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

54

Références

J Manipulative Physiol Ther. 2010 Mar-Apr;33(3):231-7
pubmed: 20350678
J Can Chiropr Assoc. 2016 Mar;60(1):13-20
pubmed: 27069262
J Can Chiropr Assoc. 2013 Dec;57(4):285-91
pubmed: 24302774
Pain Physician. 2012 Jul;15(3 Suppl):ES9-38
pubmed: 22786464
J Chiropr Educ. 2018 Oct;32(2):115-125
pubmed: 29509506
Chiropr Man Therap. 2015 Feb 02;23(1):4
pubmed: 25646145
Chiropr Man Therap. 2019 Jul 24;27:36
pubmed: 31367341
J Physiother. 2017 Oct;63(4):221-234
pubmed: 28986140
Chiropr Man Therap. 2016 Aug 24;24(1):33
pubmed: 27559468
J Manipulative Physiol Ther. 2010 Sep;33(7):519-35
pubmed: 20937430
West J Nurs Res. 2008 Oct;30(6):759-73
pubmed: 18337548
J Can Chiropr Assoc. 2020 Aug;64(2):119-130
pubmed: 33012811
Chiropr Man Therap. 2015 Jul 15;23:22
pubmed: 26180630
Chiropr Man Therap. 2014 Sep 24;22(1):34
pubmed: 25279137
Lancet. 2017 Jul 29;390(10093):437-439
pubmed: 28792397
Chiropr Osteopat. 2005 Jul 06;13:9
pubmed: 16000175
Spine J. 2010 Dec;10(12):1055-64
pubmed: 20889389
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233
pubmed: 29911818
Chiropr Man Therap. 2016 Jun 30;24:26
pubmed: 27366317
J Chiropr Med. 2011 Mar;10(1):12-7
pubmed: 22027203
J Manipulative Physiol Ther. 2015 Sep;38(7):477-83
pubmed: 26288262
J Chiropr Med. 2019 Dec;18(4):286-298
pubmed: 32952474
Lancet. 2018 Jun 9;391(10137):2368-2383
pubmed: 29573872

Auteurs

Peter C Emary (PC)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. emaryp@mcmaster.ca.
Chiropractic Department, D'Youville College, Buffalo, NY, USA. emaryp@mcmaster.ca.
Private Practice, 1145 Concession Road, Cambridge, Ontario, N3H 4L5, Canada. emaryp@mcmaster.ca.

Mark Oremus (M)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.

Taco A W Houweling (TAW)

Private Practice, Faubourg de l'Hôpital, Neuchâtel, Switzerland.

Martin Wangler (M)

Private Practice, Bern, Switzerland.

Noori Akhtar-Danesh (N)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
School of Nursing, McMaster University, Hamilton, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH